Angitia
PrivateLast Round
Series D
2/5/2026
Total Funding Raised
$420M
Momentum Score
25 /100
Company Overview
Angitia Biopharmaceuticals is a biotechnology company dedicated to the discovery and development of innovative therapies for bone, muscle, and joint diseases, aiming to provide breakthrough treatments that help patients recover from severe musculoskeletal conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Angitia Comps
Public and private peers based on sector, stage, and business model.
Angitia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | 2/5/2026 | ||||
| Series C | 12/11/2024 | ||||
| Series B Extension | 1/1/2024 | ||||
| Series B Extension | 10/19/2023 | ||||
| Series B | 11/1/2021 | ||||
Series A | 9/4/2020 |
Key People
Founding team and executive leadership
Angitia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed Asia | Series A |
| Bain Capital Life Sciences | Series D, Series C |
| Janus Henderson Group | Series D, Series C |
| RA Capital Management | Series D |
| Oriza Holdings | Series B Extension |
| Firstred Capital | Series B |
| Hillhouse Investment | Series D, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Studying 3 biologic product candidates for osteoporosis, OI, and spinal fusion.
- Feb 5, 2026
$130M round completed.
Angitia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Angitia's valuation, stock price, and market status.
